Literature DB >> 26023124

Infectious diseases. Overcoming neglect of kinetoplastid diseases.

Graeme Bilbe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26023124     DOI： 10.1126/science.aaa3683

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  16 in total

1.  Structures of Trypanosome Vacuolar Soluble Pyrophosphatases: Antiparasitic Drug Targets.

Authors:  Yunyun Yang; Tzu-Ping Ko; Chun-Chi Chen; Guozhong Huang; Yingying Zheng; Weidong Liu; Iren Wang; Meng-Ru Ho; Shang-Te Danny Hsu; Bing O'Dowd; Hannah C Huff; Chun-Hsiang Huang; Roberto Docampo; Eric Oldfield; Rey-Ting Guo
Journal:  ACS Chem Biol       Date:  2016-03-04       Impact factor: 5.100

2.  Nongenotoxic 3-Nitroimidazo[1,2-a]pyridines Are NTR1 Substrates That Display Potent in Vitro Antileishmanial Activity.

Authors:  Cyril Fersing; Louise Basmaciyan; Clotilde Boudot; Julien Pedron; Sébastien Hutter; Anita Cohen; Caroline Castera-Ducros; Nicolas Primas; Michèle Laget; Magali Casanova; Sandra Bourgeade-Delmas; Mélanie Piednoel; Alix Sournia-Saquet; Valère Belle Mbou; Bertrand Courtioux; Élisa Boutet-Robinet; Marc Since; Rachel Milne; Susan Wyllie; Alan H Fairlamb; Alexis Valentin; Pascal Rathelot; Pierre Verhaeghe; Patrice Vanelle; Nadine Azas
Journal:  ACS Med Chem Lett       Date:  2018-12-19       Impact factor: 4.345

3.  The Major Protein Arginine Methyltransferase in Trypanosoma brucei Functions as an Enzyme-Prozyme Complex.

Authors:  Lucie Kafková; Erik W Debler; John C Fisk; Kanishk Jain; Steven G Clarke; Laurie K Read
Journal:  J Biol Chem       Date:  2016-12-20       Impact factor: 5.157

4.  High-throughput sequencing of partially edited trypanosome mRNAs reveals barriers to editing progression and evidence for alternative editing.

Authors:  Rachel M Simpson; Andrew E Bruno; Jonathan E Bard; Michael J Buck; Laurie K Read
Journal:  RNA       Date:  2016-02-23       Impact factor: 4.942

5.  Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade.

Authors:  Manu De Rycker; John Thomas; Jennifer Riley; Stephen J Brough; Tim J Miles; David W Gray
Journal:  PLoS Negl Trop Dis       Date:  2016-04-15

6.  RNA Editing TUTase 1: structural foundation of substrate recognition, complex interactions and drug targeting.

Authors:  Lional Rajappa-Titu; Takuma Suematsu; Paola Munoz-Tello; Marius Long; Özlem Demir; Kevin J Cheng; Jason R Stagno; Hartmut Luecke; Rommie E Amaro; Inna Aphasizheva; Ruslan Aphasizhev; Stéphane Thore
Journal:  Nucleic Acids Res       Date:  2016-10-15       Impact factor: 16.971

7.  Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani.

Authors:  Leah S Torrie; Stephen Brand; David A Robinson; Eun Jung Ko; Laste Stojanovski; Frederick R C Simeons; Susan Wyllie; John Thomas; Lucy Ellis; Maria Osuna-Cabello; Ola Epemolu; Andrea Nühs; Jennifer Riley; Lorna MacLean; Sujatha Manthri; Kevin D Read; Ian H Gilbert; Alan H Fairlamb; Manu De Rycker
Journal:  ACS Infect Dis       Date:  2017-10-02       Impact factor: 5.084

8.  Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity.

Authors:  Pollyanna Álvaro Spósito; Ana Lia Mazzeti; Caroline de Oliveira Faria; Julio A Urbina; Gwenaelle Pound-Lana; Maria Terezinha Bahia; Vanessa Furtado Mosqueira
Journal:  Int J Nanomedicine       Date:  2017-05-17

9.  Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.

Authors:  Antoni R Blaazer; Abhimanyu K Singh; Erik de Heuvel; Ewald Edink; Kristina M Orrling; Johan J N Veerman; Toine van den Bergh; Chimed Jansen; Erin Balasubramaniam; Wouter J Mooij; Hans Custers; Maarten Sijm; Daniel N A Tagoe; Titilola D Kalejaiye; Jane C Munday; Hermann Tenor; An Matheeussen; Maikel Wijtmans; Marco Siderius; Chris de Graaf; Louis Maes; Harry P de Koning; David S Bailey; Geert Jan Sterk; Iwan J P de Esch; David G Brown; Rob Leurs
Journal:  J Med Chem       Date:  2018-05-01       Impact factor: 7.446

10.  Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.

Authors:  Shilpi Khare; Advait S Nagle; Agnes Biggart; Yin H Lai; Fang Liang; Lauren C Davis; S Whitney Barnes; Casey J N Mathison; Elmarie Myburgh; Mu-Yun Gao; J Robert Gillespie; Xianzhong Liu; Jocelyn L Tan; Monique Stinson; Ianne C Rivera; Jaime Ballard; Vince Yeh; Todd Groessl; Glenn Federe; Hazel X Y Koh; John D Venable; Badry Bursulaya; Michael Shapiro; Pranab K Mishra; Glen Spraggon; Ansgar Brock; Jeremy C Mottram; Frederick S Buckner; Srinivasa P S Rao; Ben G Wen; John R Walker; Tove Tuntland; Valentina Molteni; Richard J Glynne; Frantisek Supek
Journal:  Nature       Date:  2016-08-08       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.